225ac-psma-617
novartis
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', '225ac']
a #clinicaltrial evaluating the investigational therapy 225ac-j591 is underway for metastatic castration-resistant #prostatecancer. explains the study aims which were presented as part of a trial-in-progress update #gu23 
The Weill Cornell Medicine (WCM) Genitourinary (GU) Oncology Program provides cutting-edge care for people with prostate, kidney, bladder & testicular cancers.